Delaware
|
001-38898
|
81-3405262
|
(State or Other Jurisdiction of
Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
545 Fifth Avenue, Suite 1400
New York, NY 10017
|
10017
(Zip Code)
|
|
(Address of Principal Executive Offices)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on
which
registered
|
||
Common Stock
|
APLT
|
The Nasdaq Global Market
|
Item 5.03. |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
|
Item 5.07. |
Submission of Matters to a Vote of Security Holders.
|
1. |
The Company’s stockholders approved the Authorized Shares Increase Proposal. The numbers of shares that voted for, against and abstained from voting for or against the
Authorized Shares Increase Proposal are summarized in the table below.
|
Votes For
|
Votes Against
|
Abstentions
|
||
40,298,580
|
1,460,177
|
29,007
|
Item 9.01. |
Financial Statements and Exhibits.
|
Exhibit
No.
|
Description
|
|
Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant.
|
||
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
APPLIED THERAPEUTICS, INC.
|
||
Dated: October 28, 2022
|
By:
|
/s/ Shoshana Shendelman
|
Name:
|
Shoshana Shendelman
|
|
Title:
|
President and Chief Executive Officer
|
APPLIED THERAPEUTICS, INC.
|
||
By:
|
/s/ Shoshana Shendelman
|
|
Shoshana Shendelman, Ph.D.
|
||
President and Chief Executive Officer
|